Novartis Current Deferred Liabilities (Quarterly) Analysis

Novartis AG (NVS)

141.98 -0.29 (-0.20%) USD | NYSE | Jan 07, 16:00

142.60 +0.62 (+0.44%) Pre-Market: 06:42

View Current Deferred Liabilities (Quarterly) for NVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial

Roche Holding AG	--
Amgen, Inc.	--
AstraZeneca PLC	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Avidity Biosciences, Inc.	Upgrade